Nishan Rajakumaraswamy

Nishan Rajakumaraswamy serves as the Vice President and Head of US Clinical Development for Hematology and Solid Tumors at CARsgen Therapeutics, overseeing U.S. clinical operations and leading strategic initiatives in CAR-T therapies, including successful IND and BLA approvals in the hematology space. Prior experience includes roles as Senior Medical Director at Gilead Sciences, where responsibilities encompassed clinical development for multiple myeloma, NHL, and solid tumors, as well as global leadership in late-stage hematology programs. Nishan's career began in prestigious academic hospitals within the NHS, followed by a position as Medical Assessor at the Medicines and Healthcare products Regulatory Agency. Academic credentials include an M.D. from UCL, along with various fellowships and memberships from the Royal College of Physicians and the Royal College of Anaesthetists.